Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SIX
1851
DELISTED
Six Flags Entertainment Corp.
SIX
| $4.47M | ﹤0.01% |
+88,100
| New | +$4.78M |
|
|
ALSK
1852
DELISTED
Alaska Communications Systems
ALSK
| $4.47M | ﹤0.01% |
2,596,480
+166,210
| +7% | +$295K |
|
1853
Hurco Companies Inc
HURC
$146M
| $4.46M | ﹤0.01% |
138,582
+32,100
| +30% | +$1.07M |
|
|
OPB
1854
DELISTED
Opus Bank Common Stock
OPB
| $4.46M | ﹤0.01% |
204,704
+69,594
| +52% | +$1.48M |
|
1855
LSI Industries
LYTS
$913M
| $4.45M | ﹤0.01% |
851,571
+155,826
| +22% | +$662K |
|
1856
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
| $4.44M | ﹤0.01% |
40,800
+10,000
| +32% | +$1.08M |
|
1857
Jack in the Box
JACK
$325M
| $4.44M | ﹤0.01% |
48,700
-136,000
| -74% | -$11.3M |
|
|
EXFO
1858
DELISTED
EXFO INC.
EXFO
| $4.44M | ﹤0.01% |
1,111,840
-61,729
| -5% | -$233K |
|
1859
Nature's Sunshine
NATR
$266M
| $4.43M | ﹤0.01% |
534,821
+25,500
| +5% | +$232K |
|
1860
ICL Group
ICL
$7.16B
| $4.43M | ﹤0.01% |
884,175
-94,412
| -10% | -$471K |
|
1861
Rocky Mountain Chocolate Factory
RMCF
$11.5M
| $4.43M | ﹤0.01% |
476,101
-822
| -0.2% | -$7.36K |
|
1862
Apyx Medical
APYX
$128M
| $4.42M | ﹤0.01% |
652,800
-13,800
| -2% | -$97.9K |
|
|
PFBI
1863
DELISTED
Premier Financial Bancorp
PFBI
| $4.41M | ﹤0.01% |
256,888
+35,200
| +16% | +$557K |
|
1864
PTC Therapeutics
PTCT
$5.98B
| $4.41M | ﹤0.01% |
130,300
-238,760
| -65% | -$10.4M |
|
1865
First Financial Bancorp
FFBC
$3.61B
| $4.4M | ﹤0.01% |
179,880
-192,200
| -52% | -$4.64M |
|
|
SOHO
1866
DELISTED
Sotherly Hotels
SOHO
| $4.4M | ﹤0.01% |
658,147
+58,413
| +10% | +$401K |
|
1867
Xenon Pharmaceuticals
XENE
$6.03B
| $4.4M | ﹤0.01% |
488,600
+13,100
| +3% | +$124K |
|
|
ECHO
1868
DELISTED
Echo Global Logistics, Inc.
ECHO
| $4.4M | ﹤0.01% |
194,300
+113,200
| +140% | +$2.34M |
|
|
EGLE
1869
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $4.39M | ﹤0.01% |
143,313
-19,542
| -12% | -$649K |
|
|
AGTC
1870
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.37M | ﹤0.01% |
1,051,060
+93,260
| +10% | +$337K |
|
1871
iShares National Muni Bond ETF
MUB
$45.8B
| $4.36M | ﹤0.01% |
38,181
-46,900
| -55% | -$5.35M |
|
|
GEN
1872
DELISTED
Genesis Healthcare, Inc.
GEN
| $4.35M | ﹤0.01% |
3,921,530
+247,419
| +7% | +$286K |
|
|
MTLS
1873
Materialise
MTLS
$400M
| $4.35M | ﹤0.01% |
235,500
-20,900
| -8% | -$389K |
|
1874
Cass Information Systems
CASS
$748M
| $4.35M | ﹤0.01% |
80,489
-35,360
| -31% | -$1.81M |
|
1875
Seres Therapeutics
MCRB
$45.6M
| $4.33M | ﹤0.01% |
53,960
+1,790
| +3% | +$118K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.